EDMONTON, Alberta, March 03, 2021 (GLOBE NEWSWIRE) -- Ceapro Inc. (TSX-V: CZO; OTCQX: CRPOF) (“Ceapro” or the “Company”), a growth-stage biotechnology company focused on the development and commercialization of active ingredients for healthcare and cosmetic industries, announced today that Gilles Gagnon, President and Chief Executive Officer of Ceapro will present at the virtual H.C. Wainwright Global Life Sciences Conference taking place March 9-10, 2021.

Go here to see the original:
Ceapro Inc. to Present at the H.C. Wainwright Global Life Sciences Conference

Related Post

Leave a comment

Your email address will not be published. Required fields are marked *


Refresh